Treatment of hypertension in the elderly: A controlled clinical trial of dihydroergotoxine mesilate in comparison with nifedipine

M. Bellani, M. Meregalli, E. Guffanti

Research output: Contribution to journalArticle

Abstract

Forty-two elderly patients with systolic/diastolic or isolated systolic hypertension took part in the present clinical pilot trial designed to compare the antihypertensive actions of and tolerance to dihydroergotoxine mesilate (DHT) and nifedipine (Nif). DHT was found to have a good antihypertensive action, similar to that of Nif, on both supine and standing blood pressure (BP), after a 7-weeks treatment period. No appreciable modifications of mean pulse rate (PR) were found after either treatment. The mean final DHT dose was 6.6 mg/day and about half the patients required only 4.5 mg/day, o.d. The mean final Nif dose was 21.9% mg/day, mostly divided into two daily administrations. The frequency of side effects was lower in the group of patients taking DHT (10%) than in the Nif group (62%), but no symptoms referable to hypotension were observed. The results of this pilot trial confirm the good antihypertensive action of DHT in elderly people, similar to that of Nif, but perhaps with some advantage in terms of side effects.

Original languageEnglish
Pages (from-to)1014-1022
Number of pages9
JournalCurrent Therapeutic Research
Volume34
Issue number6
Publication statusPublished - 1983

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Treatment of hypertension in the elderly: A controlled clinical trial of dihydroergotoxine mesilate in comparison with nifedipine'. Together they form a unique fingerprint.

  • Cite this